Disproportionate impact of combination antiretroviral therapy on AIDS incidence in Australia: results from a modified back-projection model

AIDS Behav. 2012 Feb;16(2):360-7. doi: 10.1007/s10461-011-9969-z.

Abstract

The objective of the current study is to describe the impact of Combination antiretroviral therapy (cART) on trends in AIDS incidence over time for selected population groups in Australia, specifically, men who have sex with men (MSM) and injecting drug users (IDUs). A modified back-projection modeling technique was used to predict the number of AIDS diagnoses without cART based on Australia's HIV/AIDS surveillance system database. Modelled estimates indicate that since 1996, the effective cART has reduced overall AIDS cases by ~70 and ~10% among MSM and IDUs respectively. The predicted reduction in AIDS cases among IDUs aged less than 40 years was 36% while there was no reduction predicted for those aged 40 years or older. The impact of cART on AIDS diagnoses has been modest among IDUs. Late presentation, poor access to health services and barriers to uptake of cART may account for the divergence between these population groups.

MeSH terms

  • Acquired Immunodeficiency Syndrome / drug therapy*
  • Acquired Immunodeficiency Syndrome / epidemiology*
  • Adult
  • Anti-HIV Agents / therapeutic use*
  • Australia / epidemiology
  • Cross-Sectional Studies
  • Delayed Diagnosis
  • Drug Therapy, Combination
  • Health Services Accessibility
  • Homosexuality, Male / statistics & numerical data*
  • Humans
  • Incidence
  • Male
  • Models, Theoretical
  • Patient Acceptance of Health Care / statistics & numerical data*
  • Population Surveillance
  • Retrospective Studies
  • Substance Abuse, Intravenous / epidemiology*
  • Time Factors

Substances

  • Anti-HIV Agents